US5585254A
(en)
*
|
1987-08-21 |
1996-12-17 |
University Of Colorado Foundation, Inc. |
Autonomous parvovirus gene delivery vehicles and expression vectors
|
US5948634A
(en)
*
|
1988-12-21 |
1999-09-07 |
The General Hospital Coporation |
Neural thread protein gene expression and detection of alzheimer's disease
|
US6677312B1
(en)
|
1989-03-29 |
2004-01-13 |
The Johns Hopkins University |
Methods for restoring wild-type p53 gene function
|
US6800617B1
(en)
|
1989-03-29 |
2004-10-05 |
The Johns Hopkins University |
Methods for restoring wild-type p53 gene function
|
US7238673B2
(en)
*
|
1989-03-31 |
2007-07-03 |
The Regents Of The University Of Michigan |
Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
|
US5698531A
(en)
|
1989-03-31 |
1997-12-16 |
The Regents Of The University Of Michigan |
Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
|
CA2025181A1
(en)
*
|
1989-10-12 |
1991-04-13 |
William G. Weisburg |
Nucleic acid probes and methods for detecting fungi
|
US6339066B1
(en)
|
1990-01-11 |
2002-01-15 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotides which have phosphorothioate linkages of high chiral purity and which modulate βI, βII, γ, δ, Ε, ζ and η isoforms of human protein kinase C
|
US6753423B1
(en)
|
1990-01-11 |
2004-06-22 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for enhanced biostability and altered biodistribution of oligonucleotides in mammals
|
US5959096A
(en)
*
|
1992-03-16 |
1999-09-28 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotides against human protein kinase C
|
US20040142899A1
(en)
*
|
1990-01-11 |
2004-07-22 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for enhanced biostability and altered biodistribution of oligonucleotides in mammals
|
US6465188B1
(en)
*
|
1990-06-11 |
2002-10-15 |
Gilead Sciences, Inc. |
Nucleic acid ligand complexes
|
US5271941A
(en)
*
|
1990-11-02 |
1993-12-21 |
Cho Chung Yoon S |
Antisense oligonucleotides of human regulatory subunit RI.sub.α of cAMP-dependent protein kinases
|
US5989849A
(en)
*
|
1991-05-09 |
1999-11-23 |
Temple University Of The Commonwealth System Of Higher Education |
Antisense of oligonucleotides to c-kit proto-oncogene and in vitro methods
|
WO1994008003A1
(en)
*
|
1991-06-14 |
1994-04-14 |
Isis Pharmaceuticals, Inc. |
ANTISENSE OLIGONUCLEOTIDE INHIBITION OF THE ras GENE
|
US5965722A
(en)
*
|
1991-05-21 |
1999-10-12 |
Isis Pharmaceuticals, Inc. |
Antisense inhibition of ras gene with chimeric and alternating oligonucleotides
|
US5582986A
(en)
*
|
1991-06-14 |
1996-12-10 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide inhibition of the ras gene
|
CA2111472A1
(en)
*
|
1991-06-14 |
1992-12-23 |
Brett P. Monia |
Antisense oligonucleotide inhibition of the ras gene
|
CA2103377A1
(en)
*
|
1991-06-18 |
1992-12-19 |
Bruno Calabretta |
Selective inhibition of leukemic cell proliferation by bcr-abl antisense oligonucleotides
|
DK0605466T3
(en)
*
|
1991-08-23 |
2002-12-09 |
Univ Nebraska |
Methods and Preparations for Cell Reprogramming
|
US6335434B1
(en)
|
1998-06-16 |
2002-01-01 |
Isis Pharmaceuticals, Inc., |
Nucleosidic and non-nucleosidic folate conjugates
|
US8153602B1
(en)
|
1991-11-19 |
2012-04-10 |
Isis Pharmaceuticals, Inc. |
Composition and methods for the pulmonary delivery of nucleic acids
|
US5359044A
(en)
*
|
1991-12-13 |
1994-10-25 |
Isis Pharmaceuticals |
Cyclobutyl oligonucleotide surrogates
|
DE4142452A1
(en)
*
|
1991-12-18 |
1993-06-24 |
Max Planck Gesellschaft |
AGENT FOR STIMULATING THE DIVIDING ACTIVITY OF ANIMAL CELLS
|
EP0644889A4
(en)
*
|
1991-12-24 |
1996-01-10 |
Isis Pharmaceuticals Inc |
COMPOSITIONS AND METHODS FOR MODULATING -g(b)-AMYLOID.
|
US5916807A
(en)
*
|
1992-03-16 |
1999-06-29 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotides against human protein kinase C
|
US6537973B1
(en)
|
1992-03-16 |
2003-03-25 |
Isis Pharmaceuticals, Inc. |
Oligonucleotide inhibition of protein kinase C
|
US5681747A
(en)
*
|
1992-03-16 |
1997-10-28 |
Isis Pharmaceuticals, Inc. |
Nucleic acid sequences encoding protein kinase C and antisense inhibition of expression thereof
|
US5882927A
(en)
*
|
1992-03-16 |
1999-03-16 |
Isis Pharmaceuticals, Inc. |
Oligonucleotide inhibition of protein kinase C
|
US6153599A
(en)
*
|
1992-03-16 |
2000-11-28 |
Isis Pharmaceuticals, Inc. |
Methoxyethoxy oligonucleotides for modulation of protein kinase C expression
|
US5885970A
(en)
*
|
1992-03-16 |
1999-03-23 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotides against human protein kinase C
|
US5922686A
(en)
*
|
1992-03-16 |
1999-07-13 |
Isis Pharmaceuticals, Inc. |
Oligonucleotide modulation of protein kinase C
|
US6117847A
(en)
*
|
1992-03-16 |
2000-09-12 |
Isis Pharmaceuticals, Inc. |
Oligonucleotides for enhanced modulation of protein kinase C expression
|
US5948898A
(en)
*
|
1992-03-16 |
1999-09-07 |
Isis Pharmaceuticals, Inc. |
Methoxyethoxy oligonucleotides for modulation of protein kinase C expression
|
US5643780A
(en)
*
|
1992-04-03 |
1997-07-01 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for modulating RNA activity through modification of the 5' cap structure of RNA
|
US5936079A
(en)
*
|
1992-04-06 |
1999-08-10 |
Alton Ochsner Medical Foundation |
Oligonucleotide which binds to a chromosomal binding site for p53 protein
|
IL101600A
(en)
*
|
1992-04-15 |
2000-02-29 |
Yissum Res Dev Co |
Synthetic partially phosphorothioated antisense oligodeoxynucleotides and pharmaceutical compositions containing them
|
US5958764A
(en)
*
|
1992-04-30 |
1999-09-28 |
Baylor College Of Medicine |
Specific expression vectors and methods of use
|
AU669713B2
(en)
*
|
1992-04-30 |
1996-06-20 |
Baylor College Of Medicine |
Constitutive and inducible epidermal vector systems
|
EP0672137A1
(en)
*
|
1992-09-18 |
1995-09-20 |
CANJI, Inc. |
Gene therapy by retroviral vector with tumor suppressive gene
|
US6175000B1
(en)
|
1992-09-30 |
2001-01-16 |
The Salk Institute For Biological Studies |
Nucleic acids encoding human trithorax protein
|
WO1994007538A1
(en)
*
|
1992-10-01 |
1994-04-14 |
Thomas Jefferson University |
ANTISENSE OLIGONUCLEOTIDES TO B-m^_y^_b^_ PROTO-ONCOGENE
|
US5872242A
(en)
*
|
1992-10-05 |
1999-02-16 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide inhibition of ras
|
US5985558A
(en)
|
1997-04-14 |
1999-11-16 |
Isis Pharmaceuticals Inc. |
Antisense oligonucleotide compositions and methods for the inibition of c-Jun and c-Fos
|
IL108367A0
(en)
*
|
1993-01-27 |
1994-04-12 |
Hektoen Inst For Medical Resea |
Antisense polynzcleotide inhibition of human growth factor-sensitive cancer cells
|
EP0689460A4
(en)
*
|
1993-02-19 |
1996-11-13 |
Isis Pharmaceuticals Inc |
Cyclobutyl antisense oligonucleotides, methods of making and use thereof
|
US6291438B1
(en)
|
1993-02-24 |
2001-09-18 |
Jui H. Wang |
Antiviral anticancer poly-substituted phenyl derivatized oligoribonucleotides and methods for their use
|
WO1994021791A1
(en)
*
|
1993-03-16 |
1994-09-29 |
Johanna Eugenie Bergmann |
Agents for the prevention and treatment of breast cancer
|
US5468629A
(en)
*
|
1993-04-13 |
1995-11-21 |
Calhoun; Cornelia |
Method of promoting in vitro homologous recombination transfection in mammalian cells using the RecA protein
|
WO1994028720A1
(en)
*
|
1993-06-11 |
1994-12-22 |
Isis Pharmaceuticals, Inc. |
Oligomers for modulating ras oncogene
|
US5599917A
(en)
*
|
1994-03-17 |
1997-02-04 |
Pharmagenics, Inc. |
Inhibition of interferon-γ with oligonucleotides
|
US5417978A
(en)
*
|
1993-07-29 |
1995-05-23 |
Board Of Regents, The University Of Texas System |
Liposomal antisense methyl phosphonate oligonucleotides and methods for their preparation and use
|
CA2170869C
(en)
|
1993-09-03 |
1999-09-14 |
Phillip Dan Cook |
Amine-derivatized nucleosides and oligonucleosides
|
US5635385A
(en)
*
|
1993-09-15 |
1997-06-03 |
Temple University-Of The Commonwealth System Of Higher Education |
Multi-unit ribozyme inhibition of oncogene gene expression
|
IL111105A
(en)
*
|
1993-09-30 |
2009-05-04 |
Univ Pennsylvania |
Use of a molecule capable of inhibiting the expression of syk kinase to prepare a pharmaceutical composition for inhibiting phagocytosis
|
US5641863A
(en)
*
|
1993-09-30 |
1997-06-24 |
University Of Pennsylvania |
Chimeric IgG Fc receptors
|
FR2710846B1
(en)
|
1993-10-04 |
1995-12-22 |
Rhone Poulenc Rorer Sa |
Pharmaceutical compositions and their use, in particular in the treatment of neurogenerative diseases.
|
US8431119B2
(en)
*
|
1993-10-04 |
2013-04-30 |
Aventis Pharma S.A. |
Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases
|
US5807838A
(en)
*
|
1994-09-23 |
1998-09-15 |
Isis Pharmaceuticals, Inc. |
Oligonucleotide modulation of multidrug resistance-associated protein
|
US5510239A
(en)
*
|
1993-10-18 |
1996-04-23 |
Isis Pharmaceuticals, Inc. |
Oligonucleotide modulation of multidrug resistance-associated protein
|
US5612212A
(en)
*
|
1993-11-12 |
1997-03-18 |
The University Of Pennsylvania |
Selective inhibition of cell proliferation by vav antisense oligonucleotides
|
US5700657A
(en)
*
|
1993-12-13 |
1997-12-23 |
Genzyme Corporation |
Vectors and vector systems including genes encoding tumor suppressor proteins and producer cells transformed thereby
|
US5618709A
(en)
*
|
1994-01-14 |
1997-04-08 |
University Of Pennsylvania |
Antisense oligonucleotides specific for STK-1 and method for inhibiting expression of the STK-1 protein
|
US6551618B2
(en)
*
|
1994-03-15 |
2003-04-22 |
University Of Birmingham |
Compositions and methods for delivery of agents for neuronal regeneration and survival
|
US6727230B1
(en)
*
|
1994-03-25 |
2004-04-27 |
Coley Pharmaceutical Group, Inc. |
Immune stimulation by phosphorothioate oligonucleotide analogs
|
US5651981A
(en)
*
|
1994-03-29 |
1997-07-29 |
Northwestern University |
Cationic phospholipids for transfection
|
US5814619A
(en)
*
|
1994-04-08 |
1998-09-29 |
Isis Pharmacuticals, Inc. |
Oligonucleotide inhibition of P120
|
US6090626A
(en)
*
|
1994-05-31 |
2000-07-18 |
Isis Pharmaceuticals Inc. |
Antisense oligonucleotide modulation of raf gene expression
|
US5656612A
(en)
*
|
1994-05-31 |
1997-08-12 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of raf gene expression
|
KR100211178B1
(en)
*
|
1994-05-31 |
1999-07-15 |
파샬 비. 린네 |
Antisense oligonucleotide modulation of raf gene expression
|
US6358932B1
(en)
|
1994-05-31 |
2002-03-19 |
Isis Pharmaceticals, Inc. |
Antisense oligonucleotide inhibition of raf gene expression
|
US5744362A
(en)
*
|
1994-05-31 |
1998-04-28 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of raf gene expression
|
US20030119769A1
(en)
*
|
1994-05-31 |
2003-06-26 |
Monia Brett P |
Antisense oligonucleotide modulation of raf gene expression
|
US5563255A
(en)
*
|
1994-05-31 |
1996-10-08 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of raf gene expression
|
US6410518B1
(en)
|
1994-05-31 |
2002-06-25 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide inhibition of raf gene expression
|
US20060142236A1
(en)
*
|
1994-05-31 |
2006-06-29 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of raf gene expression
|
US6207646B1
(en)
*
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US7935675B1
(en)
*
|
1994-07-15 |
2011-05-03 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US20030026782A1
(en)
*
|
1995-02-07 |
2003-02-06 |
Arthur M. Krieg |
Immunomodulatory oligonucleotides
|
US6239116B1
(en)
*
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US8071737B2
(en)
*
|
1995-05-04 |
2011-12-06 |
Glead Sciences, Inc. |
Nucleic acid ligand complexes
|
US5994315A
(en)
*
|
1995-06-07 |
1999-11-30 |
East Carolina University |
Low adenosine agent, composition, kit and method for treatment of airway disease
|
US5855911A
(en)
*
|
1995-08-29 |
1999-01-05 |
Board Of Regents, The University Of Texas System |
Liposomal phosphodiester, phosphorothioate, and P-ethoxy oligonucleotides
|
GB9519299D0
(en)
*
|
1995-09-21 |
1995-11-22 |
Farrar Gwyneth J |
Genetic strategy
|
US5670325A
(en)
*
|
1996-08-14 |
1997-09-23 |
Exact Laboratories, Inc. |
Method for the detection of clonal populations of transformed cells in a genomically heterogeneous cellular sample
|
US5741650A
(en)
*
|
1996-01-30 |
1998-04-21 |
Exact Laboratories, Inc. |
Methods for detecting colon cancer from stool samples
|
US20030069195A1
(en)
*
|
1996-03-01 |
2003-04-10 |
Farrar Gwenyth Jane |
Suppression of polymorphic alleles
|
US7785842B2
(en)
*
|
1996-03-26 |
2010-08-31 |
Oncomedx, Inc. |
Comparative analysis of extracellular RNA species
|
US8043835B1
(en)
|
1996-03-26 |
2011-10-25 |
Oncomedx, Inc. |
Methods for detecting and monitoring cancer using extracellular RNA
|
ATE471150T1
(en)
*
|
1996-03-26 |
2010-07-15 |
Kopreski Michael S |
METHODS USING EXTRACELLURAER RNA EXTRACTED FROM PLASMA OR SERUM FOR DIAGNOSTIC MONITORING OR EVALUATION OF CANCER
|
US6759217B2
(en)
|
1996-03-26 |
2004-07-06 |
Oncomedx, Inc. |
Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
|
GB9606961D0
(en)
|
1996-04-02 |
1996-06-05 |
Farrar Gwyneth J |
Genetic strategy III
|
US8551970B2
(en)
*
|
1996-04-02 |
2013-10-08 |
Optigen Patents Limited |
Genetic suppression and replacement
|
US5856099A
(en)
*
|
1996-05-21 |
1999-01-05 |
Isis Pharmaceuticals, Inc. |
Antisense compositions and methods for modulating type I interleukin-1 receptor expression
|
US6300077B1
(en)
|
1996-08-14 |
2001-10-09 |
Exact Sciences Corporation |
Methods for the detection of nucleic acids
|
US5928870A
(en)
*
|
1997-06-16 |
1999-07-27 |
Exact Laboratories, Inc. |
Methods for the detection of loss of heterozygosity
|
US6203993B1
(en)
|
1996-08-14 |
2001-03-20 |
Exact Science Corp. |
Methods for the detection of nucleic acids
|
US6100029A
(en)
*
|
1996-08-14 |
2000-08-08 |
Exact Laboratories, Inc. |
Methods for the detection of chromosomal aberrations
|
US6146828A
(en)
*
|
1996-08-14 |
2000-11-14 |
Exact Laboratories, Inc. |
Methods for detecting differences in RNA expression levels and uses therefor
|
US6020137A
(en)
*
|
1996-08-14 |
2000-02-01 |
Exact Laboratories, Inc. |
Methods for the detection of loss of heterozygosity
|
US5952178A
(en)
*
|
1996-08-14 |
1999-09-14 |
Exact Laboratories |
Methods for disease diagnosis from stool samples
|
US5885834A
(en)
*
|
1996-09-30 |
1999-03-23 |
Epstein; Paul M. |
Antisense oligodeoxynucleotide against phosphodiesterase
|
US6001991A
(en)
*
|
1996-10-04 |
1999-12-14 |
Isis Pharmaceuticals Inc. |
Antisense oligonucleotide modulation of MDR P-glycoprotein gene expression
|
US6977244B2
(en)
|
1996-10-04 |
2005-12-20 |
Board Of Regents, The University Of Texas Systems |
Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
|
US6319906B1
(en)
|
1996-12-31 |
2001-11-20 |
Isis Pharmaceuticals |
Oligonucleotide compositions and methods for the modulation of the expression of B7 protein
|
US20040023917A1
(en)
*
|
1996-12-31 |
2004-02-05 |
Bennett C. Frank |
Oligonucleotide compositions and methods for the modulation of the expression of B7 protein
|
US6077833A
(en)
*
|
1996-12-31 |
2000-06-20 |
Isis Pharmaceuticals, Inc. |
Oligonucleotide compositions and methods for the modulation of the expression of B7 protein
|
US7235653B2
(en)
*
|
1996-12-31 |
2007-06-26 |
Isis Pharmaceuticals, Inc. |
Oligonucleotide compositions and methods for the modulation of the expression of B7 protein
|
US20070009934A1
(en)
*
|
1997-03-14 |
2007-01-11 |
Kopreski Michael S |
Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
|
US8440396B2
(en)
*
|
1997-03-14 |
2013-05-14 |
Oncomedx, Inc. |
Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
|
US6265388B1
(en)
|
1997-03-21 |
2001-07-24 |
President And Fellows Of Harvard College |
Antisense inhibition of angiogenin expression
|
US6406857B1
(en)
|
1997-06-16 |
2002-06-18 |
Exact Sciences Corporation |
Methods for stool sample preparation
|
US6268136B1
(en)
|
1997-06-16 |
2001-07-31 |
Exact Science Corporation |
Methods for stool sample preparation
|
DE69834038D1
(en)
|
1997-07-01 |
2006-05-18 |
Isis Pharmaceutical Inc |
COMPOSITIONS AND METHOD FOR THE ADMINISTRATION OF OLIGONUCLEOTIDES OVER THE DISHES
|
US6809193B2
(en)
|
1997-08-13 |
2004-10-26 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide compositions and methods for the modulation of JNK proteins
|
US20070149472A1
(en)
*
|
1997-08-13 |
2007-06-28 |
Mckay Robert |
Antisense oligonucleotide compositions and methods for the modulation of jnk proteins
|
US5877309A
(en)
|
1997-08-13 |
1999-03-02 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotides against JNK
|
US6133246A
(en)
*
|
1997-08-13 |
2000-10-17 |
Isis Pharmaceuticals Inc. |
Antisense oligonucleotide compositions and methods for the modulation of JNK proteins
|
US7704962B1
(en)
|
1997-10-03 |
2010-04-27 |
Board Of Regents, The University Of Texas System |
Small oligonucleotides with anti-tumor activity
|
US7285288B1
(en)
|
1997-10-03 |
2007-10-23 |
Board Of Regents, The University Of Texas System |
Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
|
US20020064792A1
(en)
*
|
1997-11-13 |
2002-05-30 |
Lincoln Stephen E. |
Database for storage and analysis of full-length sequences
|
JP4652566B2
(en)
|
1998-01-12 |
2011-03-16 |
ロビン・エイ・フェルダー |
G protein-related mutants in essential hypertension
|
CA2329130A1
(en)
*
|
1998-05-21 |
1999-11-25 |
Isis Pharmaceuticals Inc. |
Compositions and methods for non-parenteral delivery of oligonucleotides
|
US6693086B1
(en)
*
|
1998-06-25 |
2004-02-17 |
National Jewish Medical And Research Center |
Systemic immune activation method using nucleic acid-lipid complexes
|
US20030022854A1
(en)
|
1998-06-25 |
2003-01-30 |
Dow Steven W. |
Vaccines using nucleic acid-lipid complexes
|
US7157418B1
(en)
|
1998-07-22 |
2007-01-02 |
Osprey Pharmaceuticals, Ltd. |
Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
|
US20030215421A1
(en)
*
|
1999-07-21 |
2003-11-20 |
Mcdonald John R. |
Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
|
US20080261292A1
(en)
*
|
1998-09-22 |
2008-10-23 |
Oncomedx, Inc. |
Method Enabling the Use of Extracellular Ribonucleic Acid (RNA) Extracted from Plasma or Serum to Detect, Monitor or Evaluate Cancer or Premalignant Conditions
|
US20060204989A1
(en)
*
|
1998-09-22 |
2006-09-14 |
Kopreski Michael S |
Comparative analysis of extracellular RNA species
|
US8163524B2
(en)
*
|
1998-09-22 |
2012-04-24 |
Oncomedx, Inc. |
Comparative analysis of extracellular RNA species
|
DK1129064T3
(en)
|
1998-11-12 |
2008-04-28 |
Invitrogen Corp |
transfection
|
US6280947B1
(en)
|
1999-08-11 |
2001-08-28 |
Exact Sciences Corporation |
Methods for detecting nucleotide insertion or deletion using primer extension
|
US6503718B2
(en)
|
1999-01-10 |
2003-01-07 |
Exact Sciences Corporation |
Methods for detecting mutations using primer extension for detecting disease
|
DE60028732T2
(en)
|
1999-02-25 |
2007-06-14 |
Exact Sciences Corp., Maynard |
METHOD OF STABILIZING DNA INTEGRITY
|
US6964846B1
(en)
*
|
1999-04-09 |
2005-11-15 |
Exact Sciences Corporation |
Methods for detecting nucleic acids indicative of cancer
|
US6656730B1
(en)
|
1999-06-15 |
2003-12-02 |
Isis Pharmaceuticals, Inc. |
Oligonucleotides conjugated to protein-binding drugs
|
US6586177B1
(en)
*
|
1999-09-08 |
2003-07-01 |
Exact Sciences Corporation |
Methods for disease detection
|
US6849403B1
(en)
|
1999-09-08 |
2005-02-01 |
Exact Sciences Corporation |
Apparatus and method for drug screening
|
EP1238113B1
(en)
*
|
1999-12-07 |
2010-02-24 |
EXACT Sciences Corporation |
Detection of lung neoplasms in stool
|
US6919174B1
(en)
|
1999-12-07 |
2005-07-19 |
Exact Sciences Corporation |
Methods for disease detection
|
US20010044416A1
(en)
*
|
2000-01-20 |
2001-11-22 |
Mccluskie Michael J. |
Immunostimulatory nucleic acids for inducing a Th2 immune response
|
EP1158055A1
(en)
|
2000-05-26 |
2001-11-28 |
Xu Qi University of Teaxs Laboratoire de Leucémie Chen |
Method for diagnosing cancers
|
EP1950297A2
(en)
|
2000-05-31 |
2008-07-30 |
Novartis Vaccines and Diagnostics, Inc. |
Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers
|
US7105962B2
(en)
*
|
2000-08-03 |
2006-09-12 |
Matsushita Electric Industrial Co., Ltd. |
Brushless motor for partable electronic equipment with wire treatment technique of coils
|
US20110052546A1
(en)
*
|
2000-09-19 |
2011-03-03 |
University Of South Florida |
Inhibition of SHIP to Enhance Stem Cell Harvest and Transplantation
|
US20020165192A1
(en)
*
|
2000-09-19 |
2002-11-07 |
Kerr William G. |
Control of NK cell function and survival by modulation of ship activity
|
US20030096770A1
(en)
*
|
2001-07-11 |
2003-05-22 |
Krotz Achim H. |
Enhancement of the stability of oligonucleotides comprising phosphorothioate linkages by addition of water-soluble antioxidants
|
DK1421215T3
(en)
*
|
2001-07-25 |
2011-06-27 |
Oncomedx Inc |
Methods for evaluating pathological conditions using extracellular RNA
|
US7270960B2
(en)
|
2001-08-29 |
2007-09-18 |
Pacific Northwest Research Institute |
Diagnosis of ovarian carcinomas
|
US20100159464A1
(en)
*
|
2001-11-05 |
2010-06-24 |
Oncomedx, Inc. |
Method for Detection of DNA Methyltransferase RNA in Plasma and Serum
|
US20030104454A1
(en)
*
|
2001-11-05 |
2003-06-05 |
Kopreski Michael S. |
Method for detection of DNA methyltransferase RNA in plasma and serum
|
EP1470144B1
(en)
*
|
2002-02-01 |
2008-12-03 |
McGILL UNIVERSITY |
Oligonucleotides comprising alternating segments and uses thereof
|
AU2003213107A1
(en)
|
2002-02-15 |
2003-09-09 |
Exact Sciences Corporation |
Methods for analysis of molecular events
|
US20030191075A1
(en)
*
|
2002-02-22 |
2003-10-09 |
Cook Phillip Dan |
Method of using modified oligonucleotides for hepatic delivery
|
US20080214437A1
(en)
*
|
2002-09-06 |
2008-09-04 |
Mohapatra Shyam S |
Methods and compositions for reducing activity of the atrial natriuretic peptide receptor and for treatment of diseases
|
WO2004053104A2
(en)
*
|
2002-12-11 |
2004-06-24 |
Coley Pharmaceutical Group, Inc. |
5’ cpg nucleic acids and methods of use
|
US8084432B2
(en)
*
|
2003-02-13 |
2011-12-27 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for treatment of pouchitis
|
CA2521050A1
(en)
*
|
2003-04-02 |
2004-10-14 |
Coley Pharmaceutical Group, Ltd. |
Immunostimulatory nucleic acid oil-in-water formulations and related methods of use
|
US7635560B2
(en)
*
|
2003-04-17 |
2009-12-22 |
Genesis Group Inc. |
Pygopus in diagnosis and treatment of cancer
|
WO2004097017A2
(en)
*
|
2003-04-29 |
2004-11-11 |
Avi Biopharma, Inc. |
Compositions for enhancing transport and antisense efficacy of nucleic acid analog into cells
|
CN100581621C
(en)
*
|
2003-05-16 |
2010-01-20 |
拉瓦勒大学 |
CNS chloride modulation and uses thereof
|
US7897582B2
(en)
*
|
2003-05-23 |
2011-03-01 |
Isis Pharmaceuticals, Inc. |
Oligonucleotide compositions and methods for the modulation of the expression of B7 protein
|
US7960355B2
(en)
*
|
2003-05-23 |
2011-06-14 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for the modulation of the expression of B7 protein
|
US20040259101A1
(en)
*
|
2003-06-20 |
2004-12-23 |
Shuber Anthony P. |
Methods for disease screening
|
US20050013812A1
(en)
*
|
2003-07-14 |
2005-01-20 |
Dow Steven W. |
Vaccines using pattern recognition receptor-ligand:lipid complexes
|
US7807646B1
(en)
*
|
2003-11-20 |
2010-10-05 |
University Of South Florida |
SHIP-deficiency to increase megakaryocyte progenitor production
|
CA2559853A1
(en)
*
|
2004-02-17 |
2005-10-13 |
University Of South Florida |
Materials and methods for treatment of inflammatory and cell proliferation disorders
|
WO2005111244A2
(en)
*
|
2004-05-10 |
2005-11-24 |
Exact Sciences Corporation |
Methods for detecting a mutant nucleic acid
|
EP1750772A4
(en)
*
|
2004-05-14 |
2009-09-09 |
Univ Laval |
Phospholipase c gamma modulation and uses thereof for management of pain and nociception
|
WO2005113769A1
(en)
*
|
2004-05-14 |
2005-12-01 |
Exact Sciences Corporation |
Method for stabilizing biological samples for nucleic acid analysis
|
US20050288246A1
(en)
|
2004-05-24 |
2005-12-29 |
Iversen Patrick L |
Peptide conjugated, inosine-substituted antisense oligomer compound and method
|
US7700272B2
(en)
*
|
2004-06-09 |
2010-04-20 |
Mcgill University |
Polynucleotides encoding acetylcholine-gated chloride channel subunits of Caenorhabditis elegans
|
US7981607B2
(en)
*
|
2004-08-27 |
2011-07-19 |
Esoterix Genetic Laboratories LLC |
Method for detecting recombinant event
|
WO2006047787A2
(en)
|
2004-10-27 |
2006-05-04 |
Exact Sciences Corporation |
Method for monitoring disease progression or recurrence
|
WO2007044071A2
(en)
*
|
2005-04-21 |
2007-04-19 |
Exact Sciences Corporation |
Analysis of heterogeneous nucleic acid samples
|
WO2006135862A2
(en)
*
|
2005-06-10 |
2006-12-21 |
Children's Hospital And Research Center At Oakland |
Immunomodulation by altering sphingosine 1-phosphate lyase (spl) activity
|
BRPI0612408A2
(en)
*
|
2005-07-07 |
2010-11-03 |
Pfizer |
cancer therapy in combination with anti-ctla-4 antibody and synthetic oligodeoxynucleotide containing cpg motif
|
US8067571B2
(en)
|
2005-07-13 |
2011-11-29 |
Avi Biopharma, Inc. |
Antibacterial antisense oligonucleotide and method
|
CA2656990A1
(en)
*
|
2006-04-28 |
2007-11-08 |
University Of South Florida |
Materials and methods for reducing inflammation by inhibition of the atrial natriuretic peptide receptor
|
CA2660052A1
(en)
*
|
2006-08-04 |
2008-02-07 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for the modulation of jnk proteins
|
US20100016215A1
(en)
|
2007-06-29 |
2010-01-21 |
Avi Biopharma, Inc. |
Compound and method for treating myotonic dystrophy
|
US20090136942A1
(en)
*
|
2007-09-18 |
2009-05-28 |
Oncomedx, Inc. |
Analysis of Extracellular RNA
|
EP2294183B1
(en)
|
2008-06-18 |
2015-12-16 |
The Texas A&M University System |
Mesenchymal stem cells, compositions, and methods for treatment of cardiac tissue damage
|
KR20110135938A
(en)
|
2009-02-13 |
2011-12-20 |
인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 |
Compounds and methods for inhibiting mmp2 and mmp9
|
WO2011019423A2
(en)
|
2009-05-20 |
2011-02-17 |
Schering Corporation |
Modulation of pilr receptors to treat microbial infections
|
US8691227B2
(en)
|
2009-12-17 |
2014-04-08 |
Merck Sharp & Dohme Corp. |
Methods of treating multiple sclerosis, rheumatoid arthritis and inflammatory bowel disease using agonists antibodies to PILR-α
|
EP2476441A1
(en)
|
2011-01-13 |
2012-07-18 |
Universitat Autònoma De Barcelona |
Methods and reagents for efficient and targeted delivery of therapeutic molecules to CXCR4 cells
|
US10184942B2
(en)
|
2011-03-17 |
2019-01-22 |
University Of South Florida |
Natriuretic peptide receptor as a biomarker for diagnosis and prognosis of cancer
|
US9161948B2
(en)
|
2011-05-05 |
2015-10-20 |
Sarepta Therapeutics, Inc. |
Peptide oligonucleotide conjugates
|
SG11201405553YA
(en)
|
2012-03-08 |
2014-11-27 |
Halozyme Inc |
Conditionally active anti-epidermal growth factor receptor antibodies and methods of use thereof
|
CN105764924A
(en)
|
2013-09-12 |
2016-07-13 |
哈洛齐梅公司 |
Modified anti-epidermal growth factor receptor antibodies and methods of use thereof
|
EP3052512A4
(en)
|
2013-09-30 |
2017-02-22 |
Geron Corporation |
Phosphorodiamidate backbone linkage for oligonucleotides
|
CN106572974B
(en)
|
2014-07-15 |
2021-04-23 |
生命技术公司 |
Compositions and methods having lipid aggregates for efficient delivery of molecules to cells
|
US10738122B2
(en)
|
2014-09-05 |
2020-08-11 |
Rsem, Limited Partnership |
Compositions and methods for treating and preventing inflammation
|
EP3302489A4
(en)
|
2015-06-04 |
2019-02-06 |
Sarepta Therapeutics, Inc. |
Methods and compounds for treatment of lymphocyte-related diseases and conditions
|
SG10202104058XA
(en)
|
2015-10-14 |
2021-05-28 |
Bio Path Holdings Inc |
P-ethoxy nucleic acids for liposomal formulation
|
WO2017161206A1
(en)
|
2016-03-16 |
2017-09-21 |
Halozyme, Inc. |
Conjugates containing conditionally active antibodies or antigen-binding fragments thereof, and methods of use
|
WO2018053232A1
(en)
|
2016-09-16 |
2018-03-22 |
Bio-Path Holdings, Inc. |
Combination therapy with liposomal antisense oligonucleotides
|
LT3554553T
(en)
|
2016-12-19 |
2022-08-25 |
Sarepta Therapeutics, Inc. |
Exon skipping oligomer conjugates for muscular dystrophy
|
CA3058018A1
(en)
|
2017-04-19 |
2018-10-25 |
Bio-Path Holdings, Inc. |
P-ethoxy nucleic acids for stat3 inhibition
|
MA51184A
(en)
|
2017-12-15 |
2020-10-21 |
Juno Therapeutics Inc |
ANTI-CCT5 BINDING MOLECULES AND RELATED METHODS OF USE
|